Showing results (1-10 of 4,337) with videos related to

Sort By:
Pageof 434
Stapp Car Crash Journal|April 23, 2011
Sensitivity of the WorldSID 50th and ES-2re Thoraces to Loading ConfigurationXavier Trosseille, Audrey Petitjean
Postgraduate Medicine|July 3, 2013
Comparison of different adjuvant therapies for 9 resectable cancer typesMorgan Kruse, Anju Parthan, John Coombs, et al.
Stapp Car Crash Journal|August 8, 2012
Statistical simulations to evaluate the methods of the construction of injury risk curvesAudrey Petitjean, Xavier Trosseille
Current Medical Research and Opinion|April 18, 2012
Effectiveness of adjuvant imatinib in patients with gastrointestinal stromal tumor: results of a population-based, matched-cohort studyHind T Hatoum, Swu-Jane Lin, Medha Sasane, et al.
Medicine|June 28, 2024
Clinical and economic burden of medicare beneficiaries with multiple myeloma and renal impairment: An observational studyParameswaran Hari, Dominick Latremouille-Viau, Peggy Lin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 8, 2024
Critical Comments by Food and Drug Administration Reviewers on Patient-Reported Outcomes in Food and Drug Administration Regulatory Submissions (2018-2021)Christina Slota, Lindsey Norcross, Erin Comerford, et al.
BMC Health Services Research|July 11, 2014
Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare dataKathleen Lang, Huan Huang, Medha Sasane, et al.
Stapp Car Crash Journal|November 11, 2006
Thoracic injury criterion for frontal crash applicable to all restraint systemsAudrey Petitjean, Pascal Baudrit, Xavier Trosseille
Journal of Medical Economics|November 26, 2014
The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapyAnnie Guerin, Medha Sasane, Genevieve Gauthier, et al.
Transfusion|April 11, 2012
Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion needStuart L Goldberg, Er Chen, Medha Sasane, et al.
Pageof 434